EXCLUSIVE ARTICLE PACK

China's Challenges and Opportunities in the Wake of COVID-19

What’s Inside:

How China reacted to the deficiencies in primary healthcare exposed by the pandemic


Details on China’s ability to push back digital boundaries


The new ways Chinese pharma companies are finding to complete routine tasks

All Rights Reserved. Forward ® 2020

EBD Group Inc., 3150 Pio Pico Drive, Suite 201, Carlsbad, CA 92008

BACK TO TOP
Forge cross-border partnerships during ChinaBio® Partnering Forum, Delivered Digitally, August 25–27, 2020

August 25–27, 2020
China Standard Time

Gain a rare peek into the policies behind the vaccines race in China and the impact COVID-19 has had on its pharmaceutical supply chains, plus much more in this exclusive article pack from Pharma Intelligence.

Brought to you by:

DOWNLOAD
YOUR COPY TODAY